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Dear Sir, 
we have read with interest the paper by Li et al, who found that in Shanghai, China, 
to eradicate Helicobacter pylori (H. pylori) infection, the clarithromycin-containing 
regimens were repeatedly used in 178 patients (60.8%) and the levofloxacin-
containing regimens were repeated in 88 patients (30.0%). Considering the poor 
adherence (7.1%) they concluded that in order to increase the success of H. pylori 
eradication therapy, the effect of prior therapies needs to be given more 
consideration and patient education to enhance adherence also needs to be 
improved [1]. 
We completely agree with this conclusion but we would like to add our data 
regarding medical compliance to Guidelines in the Western World. In our outpatient 
clinic of Gastroenterology Unit of Molinette-SGAS Hospital, Turin, Northwestern Italy, 
there is a urea breath test (UBT) service open to all patients sent by generalists as 
well as by gastroenterologists or specialists in several disciplines. The UBT 
procedure, described elsewhere [2], is performed by dedicated nurses who carry out 
about 2000 tests per year. 
In this setting, to evaluate the rate of re-prescription of a clarithromycin plus 
amoxicillin-containing regimen after failure with the same regimen, we selected 
consecutive patients who did not respond to two anti-H. pylori treatments in the 
period 1 January 2014-1 January 2016. Furthermore, to compare eventual changes 
over time, the same strategy was retrospectively applied, searching in the database 
of our outpatient clinic, to a similar population referred in the period 1 January 2004-
1 January 2006. To test the statistical significance of the difference between two 
proportions a chi-squared test was used. The statistical significance level was set to 
95%. The statistical analysis was performed by using MedCalc software (version 
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14.8.1). We found that in the period 2014-2016 the repetition of the same treatment 
after a failure was done in 99 out of 652 (15.1%) patients versus 16 out of 409 
(3.9%) patients in the period 2004-2006 (Interval Confidence 95% [IC 95%], 
difference rate = 7.2% - 15.3%, P < 0.0001). In details, in the recent period, 
considering 99 repetitions, 78 were prescribed by generalists, 18 by 
gastroenterologists and 3 by internists. In the period 2004-2006 all repetitions were 
prescribed by generalists. Analysing the cases of repetition by specialty, the 
generalists were prescribers in 100% of the cases (in all the same doctor for each 
repeated prescription) in the period 2004-2006 and in 78.8% in the period 2014-2016 
(IC 95%, difference rate = -26% - 69%, P = 0.38). The repetition prevalence among 
gastroenterologists ranged from 0% in the period 2004-2006 to 18.2% in the period 
2014-2016 (IC 95%, difference rate = -2.7% - 39.1%), at the limit of statistical 
significance (P = 0.088). In the period 2014-2016, 75/78 (96.1%) repetitions were 
performed by the same generalist for each patient, while 11/18 (61.1%) prescriptions 
were performed by the same gastroenterologist for each patient. No prescription was 
repeated by the same internists. All patients reported an optimal compliance 
(assumption of more than 90% of prescribed drugs). 
In conclusion, also in our area there is an increasing trend to repeat the same 
treatment after a first failure. This is an important issue and could be due to reduced 
interest and knowledge about H. pylori eradication, both at general and specialist 
level. Nevertheless, it is possible that the lack of a health system informatics network 
could limit the availability of patients’ data inducing errors as the repetition of the 
treatment. This could justify the increasing number of gastroenterologists involved in 
this issue. In practice, if a patient does not show previous medical charts to the 
prescribing doctor and he does not remember in that moment the previous 
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treatments, the physician could prescribe the same therapy. Although limited by its 
retrospective design, the outcome of this study encourages the planning of updating 
courses among generalists as well as specialists for a medical education aiming to 
stimulate the appropriate application of European Guidelines [3].   
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